MASI posts strong fourth-quarter and full-year 2025 preliminary results with revenue and EPS above estimates, driven by core ...

Masimo Corporation (Nasdaq: MASI) today announced select preliminary financial results for the fourth quarter and full-year ...

In a report released today, Vik Chopra from Wells Fargo maintained a Buy rating on Masimo, with a price target of $190.00. According to TipRanks, Chopra is a 3-star analyst with an average return of 6 ...

The Irvine-based medical device maker expects Q4 revenue to increase 12% to $411 million and full year revenue to grow 9% to $1.5 billion.

Masimo Corporation (NASDAQ:MASI) is one of the best NASDAQ stocks to buy in 2026. On December 5, Wells Fargo raised the ...

Mixed bag of news for Apple as Masimo tumbles in quality despite patent win, on-device AI threatens data centers, and the Tim ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Masimo (Nasdaq: MASI) is a global technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, ...

Masimo CEO Joe Kiani, whose medical-technology company is in the midst of a proxy battle with activist Politan, revealed what he called confidential information to a major investor 12 hours before it ...

Masimo has asked a federal court to intervene in its ongoing proxy fight with Politan Capital Management, with a lawsuit that seeks to force the activist investor to “correct material misstatements ...